Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia

NCT00184054 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Competing studies

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: Arsenic Trioxide (ATO)
DRUG: Ascorbic Acid

Sponsor

University of Southern California